Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Gentronix
Gentronix
Activities:
Manufacturing
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates
The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
Gentronix's transgenic rodent mutation workflow accommodated with new lab
This continued growth follows a successful 2300 sqft expansion in 2021 to increase capacity of genetic, ocular, and skin toxicology testing in 2021
Finance
Gentronix adds capacity and services through laboratory expansion
The business has added a further 2,300 sqft to its footprint at Alderley Park in Cheshire
Finance
Gentronix expands dermal toxicology services
The addition of phototoxicity services, planned for Q2 2021, will enable the assessment of whether materials have adverse toxicity profiles after UV light activation
Regulatory
Gentronix expands sales teams in US and Europe
Appoints Dorothy Zelent and Simon Johns
Manufacturing
Gentronix signs genotoxicity assays agreement with GSK
Gentronix to provide GreenScreen HC and BlueScreen HC genotoxicity assays to GlaxoSmithKline (GSK).
Subscribe now